News & Events
iCAD & ProFound Breast Health Suite in the News
Press Releases
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023
Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-year Full-Year Operating Cash Flow ($5) million vs. ($12.8) million prior year Year ending cash balance of $21.7M NASHUA, N.H. – March 12, 2024 – iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical…
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
NASHUA, N.H. – Feb. 28, 2024 – iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, will highlight scientific presentations, including an award-winning poster at the European Congress of Radiology (ECR) annual…
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
NASHUA, NH., February 27, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, announced today the Company will release financial results for the fourth quarter and full year…
In the Media
Boca Raton hospital says artificial intelligence can detect breast cancer earlier
WPEC 12 News
C’est une première en Côte-d’Or : l’intelligence artificielle “pour détecter les cancers plus rapidement”
Franceinfo
Jura. Dole: la détection du cancer du sein renforcée par l’intelligence artificielle
leprogres.fr
Upcoming Tradeshows & Meetings
NCBC 2024 – 33rd Annual Interdisciplinary Breast Center Conference
Las Vegas, NV | March 15 – 20, 2024
SBI 2024 Breast Imaging Symposium
Booth 512 | Montréal, Canada | April 11 – 14, 2024
Webinars
From Pixels to Practice: Harnessing Innovations in Breast AI to Improve Patient Outcomes
Hear from Dr. Emily Conant, Professor of Radiology and Vice Chair of Faculty Development in the Department of Radiology at the University of Pennsylvania, Perelman School of Medicine as she reviews how new developments in Breast AI are driving advances in patient care through improved sensitivity, specificity, and workflow efficiencies….
Symposium, JFR21 Intelligence artificielle pour le cancer du sein : révolution actuelle et future pour un meilleur dépistage
Samedi 8 octobre Le Pr Bruno Boyer, CIMI, Paris explique le rôle et l’impact clinique de l’utilisation des solutions d’intelligence artificielle d’iCAD en pratique quotidienne à travers des exemples de cas cliniques et le Pr Corinne Balleyguier de l’Institut Gustave Roussy présente les résultats d’études cliniques montrant les performances des…
ProFound Insights, ProFound Impact: How Cleveland Clinic is Finding the Breast Cancers Radiologists Fear the Most
Thursday, July 20, 2023 While radiologists are trained experts in detecting breast cancer, certain types of tumors are still difficult to detect due to their elusive nature. Join us for a compelling discussion with Dr. Laura Dean, a renowned breast radiologist at the Cleveland Clinic, who will share how iCAD’s…
Contact Us
Together, we can create a world where cancer can’t hide.
Ready to experience how ProFound can save lives?